Mitchell Grants Awarded for Cancer Research


Posted on May 26, 2015 by Jennifer Ekman
Jennifer Ekman


USA researchers were recently awarded grants through the Abraham A. Mitchell Cancer Research Fund. From left, Dr. Kim Littefield, assistant vice president for research development and learning; Dr. Mike Finan, MCI director; Dr. Luda Rachek, assistant professor in the USA College of Medicine, department of pharmacology; Abraham "Abe" Mitchell; Dr. Mark Taylor, associate professor in the USA College of Medicine, department of physiology and cell biology; Dr. Glen Borchert, assistant professor in the USA department of biology; and Dr. Laurie Owen, MCI associate director for basic and translational sciences and Barbara Colle Chair for oncological sciences. data-lightbox='featured'
USA researchers were recently awarded grants through the Abraham A. Mitchell Cancer Research Fund. From left, Dr. Kim Littlefield, assistant vice president for research development and learning; Dr. Mike Finan, MCI director; Dr. Luda Rachek, assistant professor in the USA College of Medicine, department of pharmacology; Abraham "Abe" Mitchell; Dr. Mark Taylor, associate professor in the USA College of Medicine, department of physiology and cell biology; Dr. Glen Borchert, assistant professor in the USA department of biology; and Dr. Laurie Owen, MCI associate director for basic and translational sciences and Barbara Colle Chair for oncological sciences.

Three teams of University of South Alabama researchers, all working in collaboration with Mitchell Cancer Institute researchers, have been awarded grants by the Abraham A. Mitchell Cancer Research Fund.

The grants are part of an ongoing effort to link researchers at the University of South Alabama and Mitchell Cancer Institute with the longer established cancer research programs at the University of Alabama at Birmingham.

Awards for 2015 were presented to:

  • Dr. Glen Borchert, an assistant professor in the USA department of biology, for his work on “Discovery and Characterization of MicroRNAs with Undescribed Roles in Breast Cancer Pathology.” Borchert is collaborating with Dr. Yaguang Xi, an MCI faculty member.
  • Dr. Luda Rachek, an assistant professor in the USA College of Medicine  department of pharmacology, for a project on “Targeting TAT-DNA repair enzymes into mitochondria as a novel therapeutic strategy for breast cancer progression.” Rachek is working in collaboration with Dr. Ming Tan, an MCI faculty member.
  • Dr. Mark Taylor, an associate professor in the USA College of Medicine  department of physiology and cell biology, for his work on “Ca2+ Signal Patterning in Cancer.” Taylor works in collaboration with Dr. Garry Piazza from MCI and Dr. Lalita Shevde-Samant from UAB.

Abraham Mitchell created the fund with a $1 million gift to the University, hoping to encourage cancer-related and cancer-relevant research by scientists in many different University departments.

 


Share on Social Media

Archive Search

Latest University News